High-Dose PPI Plus Aspirin Reduced Esophageal Cancer Risk

Combination therapy with a high-dose proton pump inhibitor and aspirin reduced the risk of progression to esophageal cancer in patients with Barrett esophagus.

Source: CancerNetwork - July 2, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Source Type: news